Topical treatment of neuropathic bladder has been suggested as a viable alternative to oral anticholinergic therapy in children, offering greater efficacy and reduced side effects. Lazarus reviews the current status of intravesical oxybutynin use, warning that although it has proven effective in some studies, there remains a low level of evidence.
